HEALTH OF WOMAN. 2019.8(144): 72–74; doi 10.15574/HW.2019.144.72
Yu.M. Sadygov
Shupyk National Medical Academy of Postgraduate Education, Kiev

The objective: studying of clinical-anamnestic features of hyperplastic processes an endometrium at women of perimenopause age.

Materials and methods. 100 women with hyperplastic processes an endometrium during the period perimenopause (the main group) were surveyed. As selection criterion of patients and their distributions on subgroups the morphological form of hyperplastic process an endometriya served. Among the patients surveyed at 54% the glandular hyperplasia an endometrium, was diagnosed for 24% – polyps an endometrium, for 22% – an adenomatous hyperplasia an endometrium. The control group was made by 30 patients of similar age without hyperplastic processes an endometrium.

Results. The comparative analysis of the main clinical-anamnestic characteristics of women with hyperplastic processes an endometrium in the perimenopause period, I taped the following risk factors: the extragenital diseases, including illnesses of endocrine system, illness of system circulations,     diseases organs digestion; the accompanying gynecologic diseases, including inflammatory processes of genitails, dysplasia of mammary glands, hyperplastic diseases an endometrium and uterus cervix, hysteromyoma, and also transferred gynecological operations — a tubectomy, an adnexectomy. Also were allocated risk factors of development of an adenomatous hyperplasia an endometrium which treated a late menarche and early beginning of sexual life.

Conclusion. The received results needs to be considered when developing tactics ведення women of perimenopause age with hyperplastic processes an endometrium.

Key words: hyperplastic processes an endometrium, perimenopause age, clinical aspects.

REFERENCES

1. Beniuk VO, Kurochka VV, Vyniarskyi YaM, Honcharenko VM. 2013. Suchasni aspekty diahnostyky hiperplastychnykh protsesiv endometriia u zhinok reproduktyvnogo viku. Tavrycheskyi medyko-byolohycheskyi vestnyk 15;2:20–28.

2. Vdovychenko YuP, Golianovskyi OV, Lopushan IV. 2012. Suchasnyi menedzhment diahnostyky ta likuvannia hiperplastychnykh protsesiv endometriia: ogliad literatury. Zdorove zhenshchyny 9: 45–53.

3. Sidorova IS. 2017. Giperplasticheskie protsessy endometriya: osobennosti kliniki i terapii. Vrach 3: 40–42.

4. Chernuha GE. 2018. Giperplaziya endometriya: perspektivy razvitiya problemy. Akusherstvo i ginekologiya 4: 11–16.

5. Amezcua СA. 2017. Apoptosis may be an early event of progestin therapy for endometrial hyperplasia. USA. Gynecol-Oncol. 79 (2): 169–176. https://doi.org/10.1006/gyno.2000.5955; PMid:11063639

6. Buckley CH. 2018. Biopsy pathology of endomertiun. NY, Arnold.: 126.

7. Eckert LO. 2018. Endometrititis. The clinical-pathologic syndrome. Am. J. Obstet Gynecol 186(4): 690–5.